Exact Mass: 499.2023
Exact Mass Matches: 499.2023
Found 500 metabolites which its exact mass value is equals to given mass value 499.2023
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-O-(Indol-3-ylacetyl-myo-inositol) D-galactoside
Halofantrine
Halofantrine is a drug used to treat malaria. It belongs to the phenanthrene class of compounds that includes quinine and lumefantrine. It appears to inhibit polymerisation of heme molecules (by the parasite enzyme heme polymerase), resulting in the parasite being poisoned by its own waste. Halofantrine has been shown to preferentially block open and inactivated HERG channels leading to some degree of cardiotoxicity. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
13-Deoxycarminomycin
A cytotoxic anthracycline antibiotic that is produced by Streptomyces peucetius var. carminatus (a biochemical mutant of Streptomyces peucetius var. caesius), and is active against P-388 murine leukemia.
Suplatast Tosilate
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D018926 - Anti-Allergic Agents
CGS 21680
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Evodenoson
Idarubicinol
Tyr-Gly-Gly-Phe-Gly-OH
Serdexmethylphenidate
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
His Lys Ser Glu
Ser His Gln Glu
N-[4,5-dihydroxy-2-[[4-[hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2H-furan-2-yl]oxy]-6-(methoxymethyl)oxan-3-yl]acetamide
N-[4,5-dihydroxy-2-[[4-[hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2H-furan-2-yl]oxy]-6-(methoxymethyl)oxan-3-yl]acetamide
N-[4,5-dihydroxy-2-[[4-[hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2H-furan-2-yl]oxy]-6-(methoxymethyl)oxan-3-yl]acetamide [IIN-based on: CCMSLIB00000848988]
N-[4,5-dihydroxy-2-[[4-[hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2H-furan-2-yl]oxy]-6-(methoxymethyl)oxan-3-yl]acetamide [IIN-based: Match]
Ala His Ser Trp
Ala His Trp Ser
Ala Ser His Trp
Ala Ser Trp His
Ala Trp His Ser
Ala Trp Ser His
Cys Cys Phe Lys
Cys Cys Lys Phe
Cys Phe Cys Lys
Cys Phe Lys Cys
Cys His Ile Gln
Cys His Leu Gln
Cys His Gln Ile
Cys His Gln Leu
Cys Ile His Gln
Cys Ile Gln His
Cys Lys Cys Phe
Cys Lys Phe Cys
Cys Lys Ser Tyr
Cys Lys Tyr Ser
Cys Leu His Gln
Cys Leu Gln His
Cys Asn Thr Tyr
Cys Asn Tyr Thr
Cys Gln His Ile
Cys Gln His Leu
Cys Gln Ile His
Cys Gln Leu His
Cys Gln Ser Tyr
Cys Gln Tyr Ser
Cys Ser Lys Tyr
Cys Ser Gln Tyr
Cys Ser Tyr Lys
Cys Ser Tyr Gln
Cys Thr Asn Tyr
Cys Thr Tyr Asn
Cys Tyr Lys Ser
Cys Tyr Asn Thr
Cys Tyr Gln Ser
Cys Tyr Ser Lys
Cys Tyr Ser Gln
Cys Tyr Thr Asn
Asp Asp His Asn
Asp Asp Asn His
Asp His Asp Asn
Asp His Lys Thr
Asp His Asn Asp
Asp His Gln Thr
Asp His Thr Lys
Asp His Thr Gln
Asp Lys His Thr
Asp Lys Thr His
Asp Asn Asp His
Asp Asn His Asp
Asp Gln His Thr
Asp Gln Thr His
Asp Thr His Lys
Asp Thr His Gln
Asp Thr Lys His
Asp Thr Gln His
Glu His Lys Ser
Glu His Asn Thr
Glu His Gln Ser
Glu His Ser Lys
Glu His Ser Gln
Glu His Thr Asn
Glu Lys His Ser
Glu Lys Ser His
Glu Asn His Thr
Glu Asn Thr His
Glu Gln His Ser
Glu Gln Ser His
Glu Ser His Lys
Glu Ser His Gln
Glu Ser Lys His
Glu Ser Gln His
Glu Thr His Asn
Glu Thr Asn His
Phe Cys Cys Lys
Phe Cys Lys Cys
Phe Gly Asn Tyr
Phe Gly Tyr Asn
Phe Lys Cys Cys
Phe Asn Gly Tyr
Phe Asn Tyr Gly
Phe Tyr Gly Asn
Phe Tyr Asn Gly
Gly Phe Asn Tyr
Gly Phe Tyr Asn
Gly His Met Arg
Gly His Arg Met
Gly His Thr Trp
Gly His Trp Thr
Gly Met His Arg
Gly Met Arg His
Gly Asn Phe Tyr
Gly Asn Tyr Phe
Gly Arg His Met
Gly Arg Met His
Gly Thr His Trp
Gly Thr Trp His
Gly Trp His Thr
Gly Trp Thr His
Gly Tyr Phe Asn
Gly Tyr Asn Phe
His Ala Ser Trp
His Ala Trp Ser
His Cys Ile Gln
His Cys Leu Gln
His Cys Gln Ile
His Cys Gln Leu
His Asp Asp Asn
His Asp Lys Thr
His Asp Asn Asp
His Asp Gln Thr
His Asp Thr Lys
His Asp Thr Gln
His Glu Lys Ser
His Glu Asn Thr
His Glu Gln Ser
His Glu Ser Lys
His Glu Ser Gln
His Glu Thr Asn
His Gly Met Arg
His Gly Arg Met
His Gly Thr Trp
His Gly Trp Thr
His Ile Cys Gln
His Ile Gln Cys
His Lys Asp Thr
His Lys Glu Ser
His Lys Thr Asp
His Leu Cys Gln
His Leu Gln Cys
His Met Gly Arg
His Met Asn Val
His Met Arg Gly
His Met Val Asn
His Asn Asp Asp
His Asn Glu Thr
His Asn Met Val
His Asn Thr Glu
His Asn Val Met
His Gln Cys Ile
His Gln Cys Leu
His Gln Asp Thr
His Gln Glu Ser
His Gln Ile Cys
His Gln Leu Cys
His Gln Ser Glu
His Gln Thr Asp
His Arg Gly Met
His Arg Met Gly
His Ser Ala Trp
His Ser Glu Lys
His Ser Glu Gln
His Ser Lys Glu
His Ser Gln Glu
His Ser Trp Ala
His Thr Asp Lys
His Thr Asp Gln
His Thr Glu Asn
His Thr Gly Trp
His Thr Asn Glu
His Thr Gln Asp
His Thr Trp Gly
His Val Met Asn
His Val Asn Met
His Trp Ala Ser
His Trp Gly Thr
His Trp Ser Ala
His Trp Thr Gly
Ile Cys His Gln
Ile Cys Gln His
Ile His Cys Gln
Ile His Gln Cys
Ile Gln Cys His
Ile Gln His Cys
Lys Cys Cys Phe
Lys Cys Phe Cys
Lys Cys Ser Tyr
Lys Cys Tyr Ser
Lys Phe Cys Cys
Lys Ser Cys Tyr
Lys Ser Tyr Cys
Lys Tyr Cys Ser
Lys Tyr Ser Cys
Leu Cys His Gln
Leu Cys Gln His
Leu His Cys Gln
Leu His Gln Cys
Leu Gln Cys His
Leu Gln His Cys
Met Gly His Arg
Met Gly Arg His
Met His Gly Arg
Met His Asn Val
Met His Arg Gly
Met His Val Asn
Met Asn His Val
Met Asn Val His
Met Arg Gly His
Met Arg His Gly
Met Val His Asn
Met Val Asn His
Asn Cys Thr Tyr
Asn Cys Tyr Thr
Asn Asp Asp His
Asn Asp His Asp
Asn Glu His Thr
Asn Glu Thr His
Asn Phe Gly Tyr
Asn Phe Tyr Gly
Asn Gly Phe Tyr
Asn Gly Tyr Phe
Asn His Asp Asp
Asn His Glu Thr
Asn His Met Val
Asn His Thr Glu
Asn His Val Met
Asn Met His Val
Asn Met Val His
Asn Thr Cys Tyr
Asn Thr Glu His
Asn Thr His Glu
Asn Thr Tyr Cys
Asn Val His Met
Asn Val Met His
Asn Tyr Cys Thr
Asn Tyr Phe Gly
Asn Tyr Gly Phe
Asn Tyr Thr Cys
Gln Cys His Ile
Gln Cys His Leu
Gln Cys Ile His
Gln Cys Leu His
Gln Cys Ser Tyr
Gln Cys Tyr Ser
Gln Asp His Thr
Gln Asp Thr His
Gln Glu His Ser
Gln Glu Ser His
Gln His Cys Ile
Gln His Cys Leu
Gln His Asp Thr
Gln His Glu Ser
Gln His Ile Cys
Gln His Leu Cys
Gln His Ser Glu
Gln His Thr Asp
Gln Ile Cys His
Gln Ile His Cys
Gln Leu Cys His
Gln Leu His Cys
Gln Ser Cys Tyr
Gln Ser Glu His
Gln Ser His Glu
Gln Ser Tyr Cys
Gln Thr Asp His
Gln Thr His Asp
Gln Tyr Cys Ser
Gln Tyr Ser Cys
Arg Gly His Met
Arg Gly Met His
Arg His Gly Met
Arg His Met Gly
Arg Met Gly His
Arg Met His Gly
Ser Ala His Trp
Ser Ala Trp His
Ser Cys Lys Tyr
Ser Cys Gln Tyr
Ser Cys Tyr Lys
Ser Cys Tyr Gln
Ser Glu His Gln
Ser Glu Gln His
Ser His Ala Trp
Ser His Glu Gln
Ser His Trp Ala
Ser Lys Cys Tyr
Ser Lys Tyr Cys
Ser Gln Cys Tyr
Ser Gln Glu His
Ser Gln His Glu
Ser Gln Tyr Cys
Ser Trp Ala His
Ser Trp His Ala
Ser Tyr Cys Lys
Ser Tyr Cys Gln
Ser Tyr Lys Cys
Ser Tyr Gln Cys
Thr Cys Asn Tyr
Thr Cys Tyr Asn
Thr Asp His Gln
Thr Asp Gln His
Thr Glu His Asn
Thr Glu Asn His
Thr Gly His Trp
Thr Gly Trp His
Thr His Asp Gln
Thr His Glu Asn
Thr His Gly Trp
Thr His Asn Glu
Thr His Gln Asp
Thr His Trp Gly
Thr Asn Cys Tyr
Thr Asn Glu His
Thr Asn His Glu
Thr Asn Tyr Cys
Thr Gln Asp His
Thr Gln His Asp
Thr Trp Gly His
Thr Trp His Gly
Thr Tyr Cys Asn
Thr Tyr Asn Cys
Val His Met Asn
Val His Asn Met
Val Met His Asn
Val Met Asn His
Val Asn His Met
Val Asn Met His
Trp Ala His Ser
Trp Ala Ser His
Trp Gly His Thr
Trp Gly Thr His
Trp His Ala Ser
Trp His Gly Thr
Trp His Ser Ala
Trp His Thr Gly
Trp Ser Ala His
Trp Ser His Ala
Trp Thr Gly His
Trp Thr His Gly
Tyr Cys Lys Ser
Tyr Cys Asn Thr
Tyr Cys Gln Ser
Tyr Cys Ser Lys
Tyr Cys Ser Gln
Tyr Cys Thr Asn
Tyr Phe Gly Asn
Tyr Phe Asn Gly
Tyr Gly Phe Asn
Tyr Gly Asn Phe
Tyr Lys Cys Ser
Tyr Lys Ser Cys
Tyr Asn Cys Thr
Tyr Asn Phe Gly
Tyr Asn Gly Phe
Tyr Asn Thr Cys
Tyr Gln Cys Ser
Tyr Gln Ser Cys
Tyr Ser Cys Lys
Tyr Ser Cys Gln
Tyr Ser Lys Cys
Tyr Ser Gln Cys
Tyr Thr Cys Asn
Tyr Thr Asn Cys
4-[Hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2,5-dihydro-2-furanyl 2-acetamido-2-deoxy-6-O-methylhexopyranoside
methyl 4-cyano-5-[[5-cyano-2,6-bis[(3-methoxypropyl)amino]-4-methyl-3-pyridyl]azo]-3-methyl-2-thenoate
1,4,8-Tris(aminocarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane monohydriodide
Ranolazine dihydrochloride
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(4Z)-4-[[4-[[4-[bis(2-hydroxyethyl)amino]phenyl]diazenyl]phenyl]hydrazinylidene]-3-oxonaphthalene-2-carboxylic acid
N-{4-[(2-Methyl-4,5-dihydro-6H-[1,3]oxazolo[4,5-d][1]benzazepin-6-yl)carbonyl]phenyl}-2-biphenylcarboxamide
Firategrast
C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies
Evodenoson
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
2-(3,4-Difluorophenoxy)-5-fluoro-N-(cis-4-((2-hydroxy-5-methylbenzoyl)amino)cyclohexyl)nicotinamide
Lubabegron
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent Lubabegron is a potent modulator of β-adrenergic receptor (β -AR). Lubabegron demonstrates antagonistic behavior at the β1 and β?2 receptor subtypes and agonistic behavior at the β?3 receptor subtype in cattle. Lubabegron reduces NH3 gas emissions from an animal or its waste[1].
Zofenoprilat arginine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
N-(2H-benzotriazol-5-yl)-7-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]quinolin-4-amine
2-acetamido-N-[(2S,4R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-hydroxyphenyl)propanamide
[(1R,2R,3R,4R,5S,6R)-2,3,4,5-tetrahydroxy-6-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexyl] 2-(1H-indol-3-yl)acetate
2-[(2-Benzotriazol-1-yl-acetyl)-furan-2-ylmethyl-amino]-N-furan-2-ylmethyl-2-(3-methoxy-phenyl)-acetamide
4-Methyl-7-[[4-[[4-(4-nitrophenyl)-1-piperazinyl]-oxomethyl]phenyl]methoxy]-1-benzopyran-2-one
1-(1,3-benzodioxol-5-ylmethyl)-3-(4-methylphenyl)-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]urea
1-methyl-5-(piperidin-1-ylsulfonyl)-1H-indole-3-carbaldehyde N-(2-ethoxyphenyl)thiosemicarbazone
3-[(4-trimethylammoniophenyl)diazenyl]-AcTyrGlyGly
[(1R)-2-(1,3-benzodioxol-5-ylmethyl)-1-ethylsulfonyl-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[(1R,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
3-[4-[2-[[6-amino-9-[(2R,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-2-oxolanyl]-2-purinyl]amino]ethyl]phenyl]propanoic acid
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
3-(2-fluorophenyl)-1-[(2R,3S)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2S,3R)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]urea
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-7-pyridin-4-yl-1-(pyridin-4-ylmethyl)-N-(2,2,2-trifluoroethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[(1R,3R,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
N-[(1S,3S,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
3-(2-fluorophenyl)-1-[(2R,3R)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]urea
N-[[(2R,3R)-8-(4-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(2R,3S)-8-(4-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[(2R,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-phenylbenzenesulfonamide
N-[(2S,3R,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-phenylbenzenesulfonamide
N-[(2S,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-phenylbenzenesulfonamide
N-[(1R,3R,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
3-(2-fluorophenyl)-1-[(2R,3S)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]urea
(2-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(phenylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone
N-[[(2S,3S)-8-(4-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(2S,3R)-8-(4-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(2S,3S)-8-(4-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(2R,3R)-8-(4-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(2S,3R)-8-(4-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(2R,3S)-8-(4-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[(2S,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-phenylbenzenesulfonamide
N-[(2S,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-phenylbenzenesulfonamide
N-[(2R,3R,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-phenylbenzenesulfonamide
N-[(2R,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-phenylbenzenesulfonamide
N-[(2R,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-phenylbenzenesulfonamide
N-[(1R,3S,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
3-(2-fluorophenyl)-1-[(2S,3R)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2S,3S)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2S,3S)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2R,3R)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]urea
N-[(2R,4aS,12aS)-2-[2-(4-chloroanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-methylpropanamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-7-pyridin-4-yl-1-(pyridin-4-ylmethyl)-N-(2,2,2-trifluoroethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2-fluorophenyl)-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(phenylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone
[(1S)-2-(1,3-benzodioxol-5-ylmethyl)-1-ethylsulfonyl-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-N-[(1R)-1-phenylethyl]-7-[(E)-prop-1-enyl]-1-(pyrazine-2-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-N-[(1S)-1-phenylethyl]-7-[(E)-prop-1-enyl]-1-(pyrazine-2-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-N-[(1R)-1-phenylethyl]-7-[(E)-prop-1-enyl]-1-(pyrazine-2-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-N-[(1S)-1-phenylethyl]-7-[(E)-prop-1-enyl]-1-(pyrazine-2-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
[3-methoxy-2-[methyl-[(E)-10,16,16-trichlorohexadec-4-enoyl]amino]propyl] acetate
Halofantrine
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
[(2S,3S,5R,6R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-cyclohexyl] 2-(1H-indol-3-yl)acetate
3-[4-[2-[[6-Amino-9-[5-(ethylcarbamoyl)-3,4-dihydroxy-2-oxolanyl]-2-purinyl]amino]ethyl]phenyl]propanoic acid
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Osteogenic Growth Peptide (10-14)
Osteogenic Growth Peptide (10-14) (OGP(10-14)), the C-terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP-like activity. Osteogenic Growth Peptide (10-14) is responsible for the binding to the OGP receptor and activates an intracellular Gi-protein-MAP kinase signaling pathway. Osteogenic Growth Peptide (10-14) is a potent mitogen and stimulator of osteogenesis and hematopoiesis. Osteogenic Growth Peptide (10-14) acts as a Src inhibitor[1][2][3][4].